Skip to content

Minimally Invasive Surgery: Using Natural Orifice Translumenal Endoscopic Surgery (NOTES)

Natural Orifice Translumenal Endoscopic Surgery (NOTES): Laparoscopic Assisted Transgastric Appendectomy and Cholecystectomy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00531219
Acronym
NOTES
Enrollment
20
Registered
2007-09-18
Start date
2008-02-29
Completion date
2020-02-29
Last updated
2018-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appendicitis, Cholelithiasis

Keywords

appendicitis, cholelithiasis, gallstones

Brief summary

This is an observational study of pain and outcomes from patients undergoing transgastric NOTES removal of their appendix or gallbladder. Subjects who elect to have a transgastric NOTES removal of their appendix or gallbladder and agree to be in this study (through signature on the informed consent form) will be followed per standard of care, with additional follow-up for data collection including the following: * Subjects will complete a 7 day pain/temperature log after surgery * Subjects will receive a phone call at 6 months and at 1 year after surgery to capture data related to safety, adverse events, hospitalizations and patient satisfaction Additional data related to pain and outcomes will be collected at baseline/screening and at follow-up as necessary.

Interventions

PROCEDURETransgastric Appendectomy

The appendix will be removed through an incision in the stomach and pulled out through the mouth

PROCEDURETransgastric Cholecystectomy

The gallbladder will be removed through an incision in the stomach and pulled out through the mouth.

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

for the Group #1 transgastric appendectomy: 1. Males and Females between the ages of 18-75 2. Clinical diagnosis of appendicitis Emergency room evaluation within 36 hours of the onset of pain 3. ASA classification I 4. Mentally competent to give informed consent. 5. Scheduled to undergo a transgastric NOTES appendectomy.

Exclusion criteria

for group #1 transgastric appendectomy: 1. Pregnant women 2. Morbidly obese patients (Body mass index \> 35) 3. Patients who are taking immunosuppressive medications or are immunocompromised 4. Patients who are on Proton Pump Inhibitors (PPI) 5. Patients with evidence of an abdominal abscess or mass on CT scan 6. Patients who present with a clinical diagnosis of sepsis 7. Patients who have a history of open abdominal surgery 8. Patients with diffuse peritonitis 9. Patients on blood thinners or aspirin Inclusion criteria for Group #2 transgastric cholecystectomy: 1. Males and Females between the ages of 18 -75 2. Diagnosis of gallstone disease that require cholecystectomy 3. ASA classification I 4. Mentally competent to give informed consent. 5. Scheduled to undergo a transgastric NOTES cholecystectomy.

Design outcomes

Primary

MeasureTime frame
To evaluate the safety and efficacy of transgastric NOTES appendectomies and cholecystectomies (through data collection).1 year

Secondary

MeasureTime frame
To evaluate pain associated with the transgastric approach (through data collection).1 year

Countries

United States

Contacts

Primary ContactSarah Lazar, MPH
misresearch@ucsd.edu619-471-0447

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026